US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist

32.370
+0.890+2.83%

Close Oct 16 16:00 ET

1.65BMarket Cap2.97P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-61.96%886K

10.08%688K

-85.46%198K

-87.57%2.33M

-95.39%168K

-87.56%174K

Operating revenue

--0

-61.96%886K

--0

10.08%688K

-85.46%198K

-87.57%2.33M

-95.39%168K

-87.56%174K

Cost of revenue

Gross profit

Operating expense

49.92%44.15M

151.39%47.77M

48.61%129.45M

147.05%47.75M

75.62%33.24M

27.77%29.45M

-26.35%19M

3.23%87.11M

-19.75%19.33M

-12.74%18.93M

Selling and administrative expenses

-4.57%11.51M

145.72%12.85M

40.01%39.95M

177.06%14.07M

23.48%8.58M

57.16%12.06M

-40.76%5.23M

4.44%28.53M

-30.46%5.08M

1.65%6.95M

-General and administrative expense

-4.57%11.51M

145.72%12.85M

40.01%39.95M

177.06%14.07M

23.48%8.58M

57.16%12.06M

-40.76%5.23M

4.44%28.53M

-30.46%5.08M

1.65%6.95M

Research and development costs

87.71%32.64M

153.54%34.93M

52.79%89.5M

136.35%33.68M

105.89%24.66M

13.09%17.39M

-18.86%13.78M

2.65%58.58M

-15.08%14.25M

-19.36%11.98M

Operating profit

-53.50%-44.15M

-154.04%-47.77M

-51.64%-128.56M

-149.21%-47.75M

-77.25%-33.24M

-28.26%-28.76M

23.06%-18.81M

-29.14%-84.78M

6.26%-19.16M

7.58%-18.76M

Net non-operating interest income expense

1,591.43%5.92M

955.24%4.43M

634.41%6.15M

906.34%4.13M

334.38%1.25M

236.54%350K

1,100.00%420K

654.05%837K

1,105.88%410K

700.00%288K

Non-operating interest income

1,591.43%5.92M

955.24%4.43M

634.41%6.15M

906.34%4.13M

334.38%1.25M

236.54%350K

1,100.00%420K

654.05%837K

1,105.88%410K

700.00%288K

Other net income (expense)

99.68%-610K

-570.83%-483K

-3,091,314.29%-216.4M

-61,000.00%-19.55M

-33,895.83%-8.11M

-3,773,380.00%-188.66M

-140.00%-72K

94.26%-7K

-113.33%-32K

200.00%24K

Gain on sale of security

----

---83.53M

--0

---25.36M

---58.17M

----

Special income (charges)

--0

----

---113.74M

--1.84M

--14.91M

---130.49M

----

--0

-Less:Other special charges

----

--113.74M

---1.84M

---14.91M

--130.49M

----

Other non- operating income (expenses)

-7,525.00%-610K

-570.83%-483K

-273,185.71%-19.13M

-66,750.00%-21.39M

9,658.33%2.34M

-260.00%-8K

-140.00%-72K

94.26%-7K

-113.33%-32K

200.00%24K

Income before tax

82.11%-38.84M

-137.43%-43.83M

-303.59%-338.82M

-236.35%-63.18M

-117.45%-40.1M

-872.82%-217.07M

24.46%-18.46M

-27.86%-83.95M

8.03%-18.78M

9.06%-18.44M

Income tax

188.89%32K

80.88%-26K

101.44%3K

-22.22%7K

-36K

-196.45%-136K

65.22%38K

-903.85%-209K

Net income

82.11%-38.84M

-138.07%-43.86M

-304.21%-338.79M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

-27.38%-83.82M

7.94%-18.82M

10.21%-18.23M

Net income continuous Operations

82.11%-38.84M

-138.07%-43.86M

-304.21%-338.79M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

-27.38%-83.82M

7.94%-18.82M

10.21%-18.23M

Minority interest income

Net income attributable to the parent company

82.11%-38.84M

-138.07%-43.86M

-304.21%-338.79M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

-27.38%-83.82M

7.94%-18.82M

10.21%-18.23M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

82.11%-38.84M

-138.07%-43.86M

-304.21%-338.79M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

-27.38%-83.82M

7.94%-18.82M

10.21%-18.23M

Basic earnings per share

98.49%-0.86

75.46%-1.2

-97.59%-49.12

62.64%-1.7522

-92.98%-9.34

-741.33%-56.79

47.14%-4.89

0.64%-24.86

39.64%-4.69

37.55%-4.84

Diluted earnings per share

98.49%-0.86

75.46%-1.2

-97.59%-49.12

62.64%-1.7522

-92.98%-9.34

-741.33%-56.79

47.14%-4.89

0.64%-24.86

39.64%-4.69

37.55%-4.84

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	-61.96%886K	0	0	10.08%688K	-85.46%198K	-87.57%2.33M	-95.39%168K	-87.56%174K
Operating revenue	--0	--0	-61.96%886K	--0	--0	10.08%688K	-85.46%198K	-87.57%2.33M	-95.39%168K	-87.56%174K
Cost of revenue
Gross profit
Operating expense	49.92%44.15M	151.39%47.77M	48.61%129.45M	147.05%47.75M	75.62%33.24M	27.77%29.45M	-26.35%19M	3.23%87.11M	-19.75%19.33M	-12.74%18.93M
Selling and administrative expenses	-4.57%11.51M	145.72%12.85M	40.01%39.95M	177.06%14.07M	23.48%8.58M	57.16%12.06M	-40.76%5.23M	4.44%28.53M	-30.46%5.08M	1.65%6.95M
-General and administrative expense	-4.57%11.51M	145.72%12.85M	40.01%39.95M	177.06%14.07M	23.48%8.58M	57.16%12.06M	-40.76%5.23M	4.44%28.53M	-30.46%5.08M	1.65%6.95M
Research and development costs	87.71%32.64M	153.54%34.93M	52.79%89.5M	136.35%33.68M	105.89%24.66M	13.09%17.39M	-18.86%13.78M	2.65%58.58M	-15.08%14.25M	-19.36%11.98M
Operating profit	-53.50%-44.15M	-154.04%-47.77M	-51.64%-128.56M	-149.21%-47.75M	-77.25%-33.24M	-28.26%-28.76M	23.06%-18.81M	-29.14%-84.78M	6.26%-19.16M	7.58%-18.76M
Net non-operating interest income expense	1,591.43%5.92M	955.24%4.43M	634.41%6.15M	906.34%4.13M	334.38%1.25M	236.54%350K	1,100.00%420K	654.05%837K	1,105.88%410K	700.00%288K
Non-operating interest income	1,591.43%5.92M	955.24%4.43M	634.41%6.15M	906.34%4.13M	334.38%1.25M	236.54%350K	1,100.00%420K	654.05%837K	1,105.88%410K	700.00%288K
Other net income (expense)	99.68%-610K	-570.83%-483K	-3,091,314.29%-216.4M	-61,000.00%-19.55M	-33,895.83%-8.11M	-3,773,380.00%-188.66M	-140.00%-72K	94.26%-7K	-113.33%-32K	200.00%24K
Gain on sale of security	----	----	---83.53M	--0	---25.36M	---58.17M	----	----	----	----
Special income (charges)	--0	----	---113.74M	--1.84M	--14.91M	---130.49M	----	--0	--0	--0
-Less:Other special charges	----	----	--113.74M	---1.84M	---14.91M	--130.49M	----	----	----	----
Other non- operating income (expenses)	-7,525.00%-610K	-570.83%-483K	-273,185.71%-19.13M	-66,750.00%-21.39M	9,658.33%2.34M	-260.00%-8K	-140.00%-72K	94.26%-7K	-113.33%-32K	200.00%24K
Income before tax	82.11%-38.84M	-137.43%-43.83M	-303.59%-338.82M	-236.35%-63.18M	-117.45%-40.1M	-872.82%-217.07M	24.46%-18.46M	-27.86%-83.95M	8.03%-18.78M	9.06%-18.44M
Income tax	0	188.89%32K	80.88%-26K	0	101.44%3K	-22.22%7K	-36K	-196.45%-136K	65.22%38K	-903.85%-209K
Net income	82.11%-38.84M	-138.07%-43.86M	-304.21%-338.79M	-235.67%-63.18M	-119.96%-40.11M	-872.45%-217.08M	24.61%-18.42M	-27.38%-83.82M	7.94%-18.82M	10.21%-18.23M
Net income continuous Operations	82.11%-38.84M	-138.07%-43.86M	-304.21%-338.79M	-235.67%-63.18M	-119.96%-40.11M	-872.45%-217.08M	24.61%-18.42M	-27.38%-83.82M	7.94%-18.82M	10.21%-18.23M
Minority interest income
Net income attributable to the parent company	82.11%-38.84M	-138.07%-43.86M	-304.21%-338.79M	-235.67%-63.18M	-119.96%-40.11M	-872.45%-217.08M	24.61%-18.42M	-27.38%-83.82M	7.94%-18.82M	10.21%-18.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	82.11%-38.84M	-138.07%-43.86M	-304.21%-338.79M	-235.67%-63.18M	-119.96%-40.11M	-872.45%-217.08M	24.61%-18.42M	-27.38%-83.82M	7.94%-18.82M	10.21%-18.23M
Basic earnings per share	98.49%-0.86	75.46%-1.2	-97.59%-49.12	62.64%-1.7522	-92.98%-9.34	-741.33%-56.79	47.14%-4.89	0.64%-24.86	39.64%-4.69	37.55%-4.84
Diluted earnings per share	98.49%-0.86	75.46%-1.2	-97.59%-49.12	62.64%-1.7522	-92.98%-9.34	-741.33%-56.79	47.14%-4.89	0.64%-24.86	39.64%-4.69	37.55%-4.84
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data